Screening of MRSA colonization in patients undergoing total joint arthroplasty

A M Valverde Villar1, J Gutiérrez Del Álamo Oms1, I Neira Borrajo1

  • 1Department of Orthopaedic Surgery, Hospital Universitario Santa Cristina, Madrid, Spain.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) colonization affects 1.01% of patients undergoing joint arthroplasty. Screening multiple body sites, not just the nose, is crucial for accurate MRSA carrier detection to prevent periprosthetic infections.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Microbiology

Background:

  • Periprosthetic joint infection (PJI) is frequently caused by Staphylococcus aureus, particularly methicillin-resistant Staphylococcus aureus (MRSA).
  • MRSA infections lead to increased severity, costs, and poorer patient outcomes.
  • MRSA colonization affects 1-5% of the general population, presenting a significant risk factor for PJI.

Purpose of the Study:

  • To evaluate the effectiveness of a preoperative MRSA screening and decolonization protocol.
  • To determine the prevalence of MRSA colonization in patients undergoing total joint arthroplasty.
  • To assess the diagnostic yield of multi-site versus single-site (nasal) screening.

Main Methods:

  • A prospective study involving 2188 patients undergoing total joint arthroplasty.
  • Preoperative screening for MRSA colonization using swab samples from five anatomical locations.
  • MRSA-colonized patients received a 5-day preoperative treatment regimen including nasal mupirocin, chlorhexidine sponges, and oral antibiotics.

Main Results:

  • MRSA colonization was identified in 22 (1.01%) of the 2188 patients.
  • Nasal swabs alone yielded positive results in 55 patients.
  • Five patients had negative nasal cultures but positive cultures from other sites (groin, perianal), indicating potential underdiagnosis with nasal screening alone.

Conclusions:

  • The prevalence of MRSA colonization in patients undergoing hip and knee arthroplasty at this institution is 1.01%.
  • Screening multiple anatomical sites is essential, as relying solely on nasal swabs can lead to underestimation of MRSA carrier status.
  • Implementing a comprehensive screening protocol can help mitigate the risk of MRSA periprosthetic infections.